Search Results - "Cosnes, J."

Low counts of Faecalibacterium prausnitzii in colitis microbiota by Sokol, H., Seksik, P., Furet, J.P., Firmesse, O., Nion‐Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., Doré, J.

“…Background: The intestinal microbiota is suspected to play a role in colitis and particularly in inflammatory bowel disease (IBD) pathogenesis. The aim was to…”
Get full text

The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease by Delvincourt, M., Lopez, A., Pillet, S., Bourrier, A., Seksik, P., Cosnes, J., Carrat, F., Gozlan, J., Beaugerie, L., Roblin, X., Peyrin‐Biroulet, L., Sokol, H.

“…Summary Background Consequences of latent cytomegalovirus (CMV) infection reactivation on inflammatory bowel disease (IBD) flare, as a flare‐worsening factor…”
Get full text

Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery by Cosnes, J, Nion-Larmurier, I, Beaugerie, L, Afchain, P, Tiret, E, Gendre, J-P

“…Background/Aim: Immunosuppressants are now used much earlier in the course of Crohn’s disease; however their effect on the natural history of the disease,…”
Get full text

Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease by Cosnes, J., Sokol, H., Bourrier, A., Nion‐Larmurier, I., Wisniewski, A., Landman, C., Marteau, P., Beaugerie, L., Perez, K., Seksik, P.

“…Summary Background The comparative efficacy of adalimumab (ADA) and infliximab (IFX) in Crohn's disease, and the benefit of initial combotherapy with an…”
Get full text

Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn's Disease: A Prospective Cohort-Study in High-Risk Patients by Simon, M, Cosnes, J, Gornet, J M, Seksik, P, Stefanescu, C, Blain, A, Pariente, B, Nancey, S, Vuitton, L, Nachury, M, D'Haens, G, Filippi, J, Chevret, S, Laharie, D

“…Crohn's disease [CD] is associated with an increased risk of small bowel adenocarcinoma [SBA]. There are no recommendations on endoscopic screening of SBA in…”
Get full text

The outcome of infliximab dose doubling in 157 patients with ulcerative colitis after loss of response to infliximab by Dumitrescu, G., Amiot, A., Seksik, P., Baudry, C., Stefanescu, C., Gagniere, C., Allez, M., Cosnes, J., Bouhnik, Y.

“…Summary Background Optimising infliximab therapy is recommended in inflammatory bowel disease (IBD) patients who lose response to infliximab; however, there…”
Get full text

Overexpression of microRNAs-155 and 21 targeting mismatch repair proteins in inflammatory bowel diseases by Svrcek, Magali, El-Murr, Nizar, Wanherdrick, Kristell, Dumont, Sylvie, Beaugerie, Laurent, Cosnes, Jacques, Colombel, Jean-Frédéric, Tiret, Emmanuel, Fléjou, Jean-François, Lesuffleur, Thécla, Duval, Alex

“…Microsatellite instability (MSI) due to mismatch repair (MMR) deficiency is reported in 5-10% of colorectal cancers (CRCs) complicating inflammatory bowel…”
Get full text

Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine by Vernier-Massouille, G, Cosnes, J, Lemann, M, Marteau, P, Reinisch, W, Laharie, D, Cadiot, G, Bouhnik, Y, De Vos, M, Boureille, A, Duclos, B, Seksik, P, Mary, J-Y, Colombel, J-F

“…Aim: To assess the characteristics and clinical course of nodular regenerative hyperplasia (NRH) in patients with inflammatory bowel disease treated with…”
Get full text

Environmental risk factors in Crohn's disease and ulcerative colitis: an update by Carbonnel, F., Jantchou, P., Monnet, E., Cosnes, J.

“…Rapid increase in Crohn's disease (CD) and ulcerative colitis (UC) incidence in developed countries, occurrence of CD in spouses and lack of complete…”
Get full text

Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort by Vienne, A., Simon, T., Cosnes, J., Baudry, C., Bouhnik, Y., Soulé, J. C., Chaussade, S., Marteau, P., Jian, R., Delchier, J.‐C., Coffin, B., Admane, H., Carrat, F., Drouet, E., Beaugerie, L.

“…Aliment Pharmacol Ther 2011; 34: 188–195 Summary Background  Surveillance colonoscopy is recommended for inflammatory bowel disease (IBD) patients with…”
Get full text

Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprine by SEKSIK, P., COSNES, J., SOKOL, H., NION‐LARMURIER, I., GENDRE, J.‐P., BEAUGERIE, L.

“…Summary Background  There are few data on the incidence of benign infections (upper respiratory tract infections, herpes lesions and viral warts) during…”
Get full text

Impact of the diagnosis and treatment of cancer on the course of inflammatory bowel disease by Rajca, S., Seksik, P., Bourrier, A., Sokol, H., Nion-Larmurier, I., Beaugerie, L., Cosnes, J.

“…The effects of extra-intestinal cancer on the course of inflammatory bowel disease (IBD) are poorly understood. To evaluate the impact of cancer and its…”
Get full text

Review article: smoking cessation as primary therapy to modify the course of Crohn's disease by Johnson, G. J., Cosnes, J., Mansfield, J. C.

“…Summary This article aims to offer an updated review of the effects of smoking on inflammatory bowel disease, and provide a review of the methods of achieving…”
Get full text

Crohn's disease clinical course and severity in obese patients by BLAIN, A., CATTAN, S., BEAUGERIE, L., CARBONNEL, F., GENDRE, J.P., COSNES, J.

“…Background and aims: Obesity is unusual in Crohn's disease and the particularities of the disease in obese patients have not been studied. Methods: 2065…”
Get full text

Benefit of Infliximab Reintroduction after Successive Failure of Infliximab and Adalimumab in Crohn’s Disease by Gagniere, C, Beaugerie, L, Pariente, B, Seksik, P, Amiot, A., Abitbol, V, Allez, M, Cosnes, J, Sokol, H

“…Background: Infliximab [IFX] and adalimumab [ADA] are effective in Crohn’s disease [CD] for induction and maintenance therapy. However, high annual rate of…”
Get full text

Effects of cigarette smoking on the long-term course of Crohn's disease by Cosnes, J, Carbonnel, F, Beaugerie, L, Le Quintrec, Y, Gendre, JP

“…BACKGROUND & AIMS: In Crohn's disease, smoking increases the risk for surgical procedures. The influence of smoking on the overall severity of the disease…”
Get full text

Infliximab for refractory ulcerative colitis or indeterminate colitis: an open‐label multicentre study by Gornet, J.‐M., Couve, S., Hassani, Z., Delchier, J.‐C., Marteau, P., Cosnes, J., Bouhnik, Y., Dupas, J.‐L., Modigliani, R., Taillard, F., Lemann, M.

“…Summary Background : The efficacy of infliximab in ulcerative colitis (UC) and indeterminate colitis has been poorly assessed and preliminary results are…”
Get full text

Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis by Svrcek, M, Cosnes, J, Beaugerie, L, Parc, R, Bennis, M, Tiret, E, Fléjou, J-F

“…Aims:  To determine the clinicopathological features of colorectal cancer (CRC) in Crohn's disease (CD). Methods and results:  All histological slides from…”
Get full text

Complications of celiac disease by Cosnes, J, Nion-Larmurier, I

“…Numerous complications can occur in celiac disease, nutritional (growth failure in children, malnutrition, vitamin deficiencies), hematologic (anaemia), bone…”
Get full text

Impact of pregnancy on the clinical activity of Crohn's disease by Agret, F., Cosnes, J., Hassani, Z., Gornet, J.‐M., Gendre, J.‐P., Lémann, M., Beaugerie, L.

“…Summary Background : The impact of pregnancy on Crohn's disease activity has been poorly investigated. Aim : To determine the effect of pregnancy on Crohn's…”
Get full text